Core Viewpoint - Ademi LLP is investigating Apellis Pharmaceuticals Inc. for potential breaches of fiduciary duty and other legal violations related to its transaction with Biogen, focusing on whether shareholders are receiving a fair price [1][4]. Transaction Details - Apellis stockholders will receive $41 per share plus a contingent value right, which includes additional payments based on the sales performance of SYFOVRE [3]. - Under the contingent value rights, shareholders could receive $2 per share if SYFOVRE achieves $1.5 billion in annual global net sales between 2027 and 2030, and another $2 per share if it reaches $2 billion in annual sales during the same period. If these thresholds are not met but SYFOVRE achieves $2 billion in sales in 2031, shareholders would receive $4 per share [3]. Board Conduct and Shareholder Rights - The transaction agreement imposes significant penalties on Apellis for accepting competing bids, which raises concerns about the board's fulfillment of fiduciary duties to all shareholders [4]. - Apellis insiders are set to receive substantial benefits as part of the change of control arrangements, further complicating the fairness of the transaction for public shareholders [4].

Core Viewpoint - Robbins LLP has filed a class action lawsuit on behalf of investors who purchased Pinterest, Inc. (NYSE: PINS) securities between February 7, 2025, and February 12, 2026, alleging that the company misled investors regarding its advertising revenues [1][2]. Allegations - The lawsuit claims that Pinterest failed to disclose significant issues affecting its advertising revenues, including reduced revenues from advertising partners and the impact of U.S. tariffs on its business operations [2]. - It is alleged that Pinterest overstated its ability to manage these macroeconomic challenges, leading to misleading public statements about its financial health [2]. Financial Performance - On February 12, 2026, Pinterest reported quarterly revenue of $1.32 billion, which was below the consensus estimate of $1.33 billion. The company also provided Q1 2026 revenue guidance of $951 million to $971 million, falling short of the consensus estimate of $980.6 million [3]. - CEO William Ready attributed the company's performance to "exogenous shock" related to tariffs, which disproportionately affected advertising spending from top retail advertisers. CFO Julia Donnelly indicated that these tariff-related headwinds are expected to continue and may worsen in Q1 [3]. Stock Impact - Following the announcement of disappointing financial results, Pinterest's stock price dropped by $3.12 per share, or 16.83%, closing at $15.42 on February 13, 2026 [3].

Core Viewpoint - Ademi LLP is investigating Kezar Life Sciences, Inc. for potential breaches of fiduciary duty and other legal violations related to its transaction with Aurinia, focusing on whether shareholders are receiving a fair price [1][4]. Transaction Details - In the announced transaction, Kezar stockholders will receive $6.955 in cash per share along with one contingent value right (CVR) [3]. - The CVR includes rights to potential payments from the clinical development of zetomipzomib, proceeds from Kezar's collaboration with Everest Medicines, and the sale of its Sec61-based program to Enodia Therapeutics, as well as 100% of Kezar's closing net cash exceeding $50 million, net of certain expenses [3]. Board Conduct Investigation - The transaction agreement imposes significant penalties on Kezar for accepting competing bids, which raises concerns about the board's fulfillment of fiduciary duties to all shareholders [4]. - Ademi LLP specializes in shareholder litigation involving buyouts, mergers, and individual shareholder rights, indicating a focus on protecting shareholder interests [4].

Core Viewpoint - Ecopetrol's Board of Directors is committed to protecting the interests of the company and its shareholders while ensuring transparency and good corporate governance [1] Group 1: Company Overview - Ecopetrol is Colombia's largest company and a leading integrated energy firm in the Americas, employing over 19,000 individuals [2] - The company is responsible for more than 60% of Colombia's hydrocarbon production and has significant roles in transportation, logistics, refining, petrochemicals, and gas distribution [2] - Ecopetrol has expanded its influence by acquiring 51.4% of ISA's shares, enhancing its participation in energy transmission and management [2][3] Group 2: Board of Directors' Actions - The Board discussed the request from the UNIÓN SINDICAL OBRERA (USO) for the removal of President Ricardo Roa Barragán, indicating potential nationwide worker mobilization if no action is taken [2] - Minority shareholders have raised concerns regarding public disclosures related to formal charges against the President and potential regulatory non-compliance [2] - The Board is actively assessing risks associated with news reports about Dr. Roa, supported by internal and external advisors, and has implemented monitoring measures [2] Group 3: Compliance and Transparency - The Board emphasized its commitment to due diligence and has confirmed that there have been no violations of regulations or breaches of contracts related to the current situation [2] - Ecopetrol is continuously monitoring various proceedings against the company and its representatives to ensure accurate information is provided to investors and the public [2]

Core Viewpoint - Ademi LLP is investigating Terns Pharmaceuticals Inc. for potential breaches of fiduciary duty and other legal violations related to its transaction with Merck, raising concerns about whether shareholders are receiving a fair price [1][3]. Group 1: Transaction Details - Terns stockholders are set to receive $53.00 per share in cash, which equates to an equity value of approximately $6.7 billion, or $5.7 billion net of acquired cash [2]. - The transaction agreement includes provisions that significantly limit competing offers for Terns, imposing a substantial penalty if Terns accepts a competing bid [3]. Group 2: Board Conduct - The investigation focuses on the conduct of Terns' board of directors to determine if they are fulfilling their fiduciary duties to all shareholders [3].

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Canadian Solar Inc. due to reported losses and possible non-compliance with federal securities laws [1][4]. Group 1: Investigation Details - The investigation focuses on whether Canadian Solar's executive officers may have caused investor losses that could be recovered under federal securities laws [1]. - Investors who purchased Canadian Solar securities and suffered losses are encouraged to join the investigation [2]. Group 2: Financial Performance - On March 19, 2026, Canadian Solar announced its Q4 2025 and full-year financial results, revealing a sequential decline in key operating metrics [3]. - The company reported a double-digit percentage drop in solar module shipments and a quarter-over-quarter revenue contraction from Q3 levels, along with guidance for lower gross margins [3].

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of AirSculpt Technologies, Inc. due to significant losses reported by the company, focusing on whether these losses can be recovered under federal securities laws [1][4]. Financial Performance - On November 7, 2025, AirSculpt reported a revenue decline of approximately 17.8% year-over-year, totaling around $35 million [3]. - The company experienced a case volume decline of approximately 15.2% year-over-year and a same-store revenue decline of approximately 22% [3]. - AirSculpt reported a net loss of approximately $9.5 million for the third quarter of 2025 [3]. Market Reaction - Following the earnings call where management acknowledged that third quarter revenue was lower than anticipated, the stock price of AirSculpt Technologies declined significantly [4]. Legal Investigation - Johnson Fistel is investigating whether AirSculpt Technologies complied with federal securities laws in light of the financial disclosures and subsequent stock price decline [4].

Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of Five9, Inc. [1] Group 1: Shareholder Rights and Options - Long-term shareholders of Five9 may seek corporate governance reforms, return of funds, court-approved financial incentives, or other benefits [2] - Shareholder involvement is crucial for improving company policies and enhancing shareholder value [3] Group 2: Legal Representation and Achievements - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, recovering millions for defrauded investors [4]

Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of ZoomInfo Technologies Inc. [1] Group 1: Legal Rights and Options for Shareholders - Long-term shareholders of ZoomInfo may seek corporate governance reforms, financial incentives, or other benefits [2] - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their rights and options at no cost [1][2] Group 2: Importance of Shareholder Participation - Shareholder involvement is crucial for improving company policies and practices, leading to enhanced transparency and accountability [3] Group 3: Halper Sadeh LLC's Role - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, recovering millions for defrauded investors [4]

Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of United Natural Foods, Inc. (NYSE: UNFI) towards shareholders [1]. Group 1: Shareholder Rights and Options - Long-term shareholders of United Natural Foods may seek corporate governance reforms, financial incentives, or other benefits [2]. - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their rights and options at no cost [1][2]. Group 2: Importance of Shareholder Participation - Shareholder involvement is crucial for improving company policies and practices, leading to enhanced transparency and accountability, which can ultimately increase shareholder value [3]. Group 3: Legal Representation and Achievements - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered millions for defrauded investors [4].